Bausch Health Companies Inc. (TSX:BHC)

Market Cap	2.47B
Revenue (ttm)	13.99B
Net Income (ttm)	-57.49M
Shares Out	n/a
EPS (ttm)	-0.16
PE Ratio	n/a
Forward PE	1.19
Dividend	n/a
Ex-Dividend Date	n/a

Volume	476,322
Average Volume	487,841
Open	6.62
Previous Close	6.38
Day's Range	6.62 - 6.92
52-Week Range	5.45 - 13.74
Beta	0.43
RSI	40.54
Earnings Date	Apr 30, 2025

About Bausch Health Companies

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products. The Intern...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Thomas Appio
• Employees: 20,700
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: BHC

Financial Performance

In 2024, Bausch Health Companies's revenue was $9.63 billion, an increase of 9.91% compared to the previous year's $8.76 billion. Losses were -$46.00 million, -92.23% less than in 2023.

Financial numbers in USD